Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis.
Although surgical lung resection could improve prognosis in some patients with multidrug-resistant tuberculosis (MDR-TB), there are no reports on the optimal candidates for this surgery. The aim of the present study was to elucidate the prognostic factors for surgery in patients with MDR-TB. Patients who underwent lung resection for the treatment of MDR-TB between March 1993 and December 2004 were included in the present study. Treatment failure was defined as greater than or equal to two of the five cultures recorded in the final 12 months of treatment being positive, any one of the final three cultures being positive, or the patient having died during treatment. The variables that affected treatment outcomes were identified through univariate and multivariate logistic regression analysis. In total, 79 patients with MDR-TB were included in the present study. The treatment outcomes of 22 (27.8%) patients were classified as failure. A body mass index <18.5 kg x m(-2), primary resistance, resistance to ofloxacin and the presence of a cavitary lesion beyond the range of the surgical resection were associated with treatment failure. Low body mass index, primary resistance, resistance to ofloxacin and cavitary lesions beyond the range of resection are possible poor prognostic factors for surgical lung resection in multidrug-resistant tuberculosis patients.
Kim
H J
HJ
Division of Pulmonary and Critical Care Medicine, Dept of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kang
C H
CH
Kim
Y T
YT
Sung
S-W
SW
Kim
J H
JH
Lee
S M
SM
Yoo
C-G
CG
Lee
C-T
CT
Kim
Y W
YW
Han
S K
SK
Shim
Y-S
YS
Yim
J-J
JJ
D000328:Adult; D000368:Aged; D015415:Biomarkers; D015992:Body Mass Index; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D008168:Lung / Q000382:microbiology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification; D015242:Ofloxacin / Q000494:pharmacology; D011379:Prognosis; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000601:surgery*; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000601:surgery*
D015415:Biomarkers; D015242:Ofloxacin